HKEX:8430 stock news
This page provides real-time market news, earnings updates, and company announcements related to C&N Holdings Limited (HKEX:8430).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 01:01 HKT
Fold Holdings, Inc. (NASDAQ: FLD) Announces Fourth Quarter and Full Year 2025 Results
Finviz2026-03-17 20:18:52
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer's Disease/Parkinson's Disease 2026 International Conference (AD/PD)
Finviz2026-03-18 12:03:48
Meta Establishes New York City Retail Flagship at Vornado Realty Trust's 697 Fifth Avenue
Finviz2026-03-18 12:27:51
Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
Finviz2026-03-18 12:33:43
FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-03-20 20:06:48
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 12:33:50
Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout
Finviz2026-03-23 12:33:50
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
Finviz2026-03-24 11:03:57
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
Finviz2026-03-25 12:33:50
OceanPal Inc. Reports Financial Results for the Year Ended December 31, 2025, and Introduces 2026 Guidance
Finviz2026-03-26 12:18:48
Here’s Why Keeping Integer Holdings Stock in Your Portfolio Makes Sense
101 finance2026-03-26 14:16:24
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
Finviz2026-03-28 15:03:53
FLOWERS FOODS ANNOUNCES DEPARTURE OF CHIEF GROWTH OFFICER TERRY THOMAS
Finviz2026-03-30 13:03:04
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-30 20:33:43
Broadridge Surges 3.82% on Strong Earnings and Strategic Shifts as Institutional Buying Outpaces Selling
101 finance2026-03-30 23:27:48
Lantern Pharma’s Q4 2025 Earnings Call: Q&A Absence and HARMONIC Trial Data Timeline Contradictions
101 finance2026-03-31 00:25:02
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting
Finviz2026-03-31 12:06:47
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect
Finviz2026-03-31 22:03:44
Skillz Platform Inc.'s Q4 Earnings Call Contradictions: Developer Exodus, GMV Surge, and UA Spend Rescaling Clash With Prior Claims
101 finance2026-04-02 01:39:43
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
Finviz2026-04-02 11:03:12
Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response
Finviz2026-04-02 11:03:13
Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital
Finviz2026-04-07 12:03:48
Zillow’s AI Pivot vs. Rising Rates: The Widening Expectation Gap Driving the Sell-Off
101 finance2026-04-08 07:06:44
Garmin unveils D2 Mach 2 Pro, its first aviator smartwatch with inReach technology
Finviz2026-04-14 11:00:53
FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-03-20 20:06:48
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 12:33:50
Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout
Finviz2026-03-23 12:33:50
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
Finviz2026-03-24 11:03:57
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
Finviz2026-03-25 12:33:50
OceanPal Inc. Reports Financial Results for the Year Ended December 31, 2025, and Introduces 2026 Guidance
Finviz2026-03-26 12:18:48
Here’s Why Keeping Integer Holdings Stock in Your Portfolio Makes Sense
101 finance2026-03-26 14:16:24
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
Finviz2026-03-28 15:03:53
FLOWERS FOODS ANNOUNCES DEPARTURE OF CHIEF GROWTH OFFICER TERRY THOMAS
Finviz2026-03-30 13:03:04
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-30 20:33:43
Broadridge Surges 3.82% on Strong Earnings and Strategic Shifts as Institutional Buying Outpaces Selling
101 finance2026-03-30 23:27:48
Lantern Pharma’s Q4 2025 Earnings Call: Q&A Absence and HARMONIC Trial Data Timeline Contradictions
101 finance2026-03-31 00:25:02
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting
Finviz2026-03-31 12:06:47
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect
Finviz2026-03-31 22:03:44
Skillz Platform Inc.'s Q4 Earnings Call Contradictions: Developer Exodus, GMV Surge, and UA Spend Rescaling Clash With Prior Claims
101 finance2026-04-02 01:39:43
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
Finviz2026-04-02 11:03:12
Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response
Finviz2026-04-02 11:03:13
Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital
Finviz2026-04-07 12:03:48
Zillow’s AI Pivot vs. Rising Rates: The Widening Expectation Gap Driving the Sell-Off
101 finance2026-04-08 07:06:44
Garmin unveils D2 Mach 2 Pro, its first aviator smartwatch with inReach technology
Finviz2026-04-14 11:00:53
HKEX:8430 stock price change
On the last trading day, HKEX:8430 stock closed at 0.07 HKD, with a price change of 4.29% for the day.
Trade stock perpsHKEX:8430 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more